Full text
PDF











Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- AVIADO D. M., Jr Cardiovascular effects of some commonly used pressor amines. Anesthesiology. 1959 Jan-Feb;20(1):71–97. doi: 10.1097/00000542-195901000-00012. [DOI] [PubMed] [Google Scholar]
- AVIADO D. M., Jr, WNUCK A. L. Mechanisms for cardiac slowing by methoxamine. J Pharmacol Exp Ther. 1957 Jan;119(1):99–106. [PubMed] [Google Scholar]
- BLACK J. W., CROWTHER A. F., SHANKS R. G., SMITH L. H., DORNHORST A. C. A NEW ADRENERGIC BETARECEPTOR ANTAGONIST. Lancet. 1964 May 16;1(7342):1080–1081. doi: 10.1016/s0140-6736(64)91275-9. [DOI] [PubMed] [Google Scholar]
- BLACK J. W., STEPHENSON J. S. Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide). Lancet. 1962 Aug 18;2(7251):311–314. doi: 10.1016/s0140-6736(62)90103-4. [DOI] [PubMed] [Google Scholar]
- Black J. W., Duncan W. A., Shanks R. G. Comparison of some properties of pronethalol and propranolol. Br J Pharmacol Chemother. 1965 Dec;25(3):577–591. doi: 10.1111/j.1476-5381.1965.tb01782.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DONALD D. E., KVALE J., SHEPHERD J. T. THE EFFECT OF AN ADRENERGIC BETA-RECEPTOR ANTAGONIST ON THE CARDIOVASCULAR SYSTEM OF THE DOG. J Pharmacol Exp Ther. 1964 Mar;143:344–349. [PubMed] [Google Scholar]
- FURCHGOTT R. F. The receptors for epinephrine and norepinephrine (adrenergic receptors). Pharmacol Rev. 1959 Jun;11(2 Pt 2):429–442. [PubMed] [Google Scholar]
- GLICK G., BRAUNWALD E. RELATIVE ROLES OF THE SYMPATHETIC AND PARASYMPATHETIC NERVOUS SYSTEMS IN THE REFLEX CONTROL OF HEART RATE. Circ Res. 1965 Apr;16:363–375. doi: 10.1161/01.res.16.4.363. [DOI] [PubMed] [Google Scholar]
- GLOVER W. E., GREENFIELD A. D., SHANKS R. G. Effect of dichloroisoprenaline on the peripheral vascular responses to adrenaline in man. Br J Pharmacol Chemother. 1962 Oct;19:235–244. doi: 10.1111/j.1476-5381.1962.tb01185.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GREEN H. D., KEPCHAR J. H. Control of peripheral resistance in major systemic vascular beds. Physiol Rev. 1959 Jul;39(3):617–686. doi: 10.1152/physrev.1959.39.3.617. [DOI] [PubMed] [Google Scholar]
- MAXWELL G. M., ROBERTSON E., ELLIOTT R. B. THE EFFECTS OF A NEW BETA ADRENERGIC BLOCKING AGENT (NETHALIDE; ALDERLIN) UPON THE GENERAL AND CORONARY HAEMODYNAMICS OF THE INTACT ANIMAL. Aust J Exp Biol Med Sci. 1963 Oct;41:511–515. doi: 10.1038/icb.1963.41. [DOI] [PubMed] [Google Scholar]
- MORAN N. C., PERKINS M. E. Adrenergic blockade of the mammalian heart by a dichloro analogue of isoproterenol. J Pharmacol Exp Ther. 1958 Nov;124(3):223–237. [PubMed] [Google Scholar]
- ORLANS F. B., FINGER K. F., BRODIE B. B. Pharmacological consequences of the selective release of peripheral norepinephrine by syrosingopine (Su 3118). J Pharmacol Exp Ther. 1960 Feb;128:131–139. [PubMed] [Google Scholar]
- POWELL C. E., SLATER I. H. Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol. J Pharmacol Exp Ther. 1958 Apr;122(4):480–488. [PubMed] [Google Scholar]
- STONE C. A., ROSS C. A., WENGER H. C., LUDDEN C. T., BLESSING J. A., TOTARO J. A., PORTER C. C. Effect of alpha-methyl-3,4-dihydroxyphenylalanine (methyldopa), reserpine and related agents on some vascular responses in the dog. J Pharmacol Exp Ther. 1962 Apr;136:80–88. [PubMed] [Google Scholar]